| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 DNAH3 MYH8 ABCA1 RABL2B RABL2A SEPTIN4 LRRK2 DDX56 FANCM | 2.21e-05 | 775 | 51 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 DNAH3 MYH8 ABCA1 RABL2B RABL2A SEPTIN4 LRRK2 DDX56 FANCM | 4.34e-05 | 839 | 51 | 10 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 DNAH3 MYH8 ABCA1 RABL2B RABL2A SEPTIN4 LRRK2 DDX56 FANCM | 4.38e-05 | 840 | 51 | 10 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 DNAH3 MYH8 ABCA1 RABL2B RABL2A SEPTIN4 LRRK2 DDX56 FANCM | 4.38e-05 | 840 | 51 | 10 | GO:0016818 |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.19e-04 | 189 | 51 | 5 | GO:0004721 | |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 4.15e-04 | 12 | 51 | 2 | GO:1990817 | |
| GeneOntologyMolecularFunction | phosphatase activity | 8.10e-04 | 287 | 51 | 5 | GO:0016791 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 8.49e-04 | 17 | 51 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 8.49e-04 | 17 | 51 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 8.71e-04 | 441 | 51 | 6 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 8.98e-04 | 614 | 51 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | syntaxin binding | 1.43e-03 | 87 | 51 | 3 | GO:0019905 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 2.32e-03 | 103 | 51 | 3 | GO:0004725 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 2.84e-03 | 31 | 51 | 2 | GO:0070566 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.98e-03 | 386 | 51 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.41e-03 | 118 | 51 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.24e-03 | 38 | 51 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | SNARE binding | 5.07e-03 | 136 | 51 | 3 | GO:0000149 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 5.14e-03 | 439 | 51 | 5 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 5.14e-03 | 439 | 51 | 5 | GO:0019001 | |
| GeneOntologyCellularComponent | SAGA complex | 2.85e-05 | 25 | 50 | 3 | GO:0000124 | |
| GeneOntologyCellularComponent | SAGA-type complex | 1.11e-04 | 39 | 50 | 3 | GO:0070461 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.56e-04 | 238 | 50 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | Fanconi anaemia nuclear complex | 5.77e-04 | 15 | 50 | 2 | GO:0043240 | |
| GeneOntologyCellularComponent | muscle myosin complex | 6.59e-04 | 16 | 50 | 2 | GO:0005859 | |
| GeneOntologyCellularComponent | intraciliary transport particle B | 1.14e-03 | 21 | 50 | 2 | GO:0030992 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.48e-03 | 94 | 50 | 3 | GO:0000123 | |
| GeneOntologyCellularComponent | motile cilium | 1.55e-03 | 355 | 50 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | myosin filament | 1.62e-03 | 25 | 50 | 2 | GO:0032982 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.70e-03 | 214 | 50 | 4 | GO:0036126 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.98e-03 | 104 | 50 | 3 | GO:0031248 | |
| GeneOntologyCellularComponent | myosin II complex | 2.04e-03 | 28 | 50 | 2 | GO:0016460 | |
| GeneOntologyCellularComponent | intraciliary transport particle | 2.04e-03 | 28 | 50 | 2 | GO:0030990 | |
| GeneOntologyCellularComponent | pericentriolar material | 2.04e-03 | 28 | 50 | 2 | GO:0000242 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.26e-03 | 109 | 50 | 3 | GO:1902493 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 2.62e-03 | 241 | 50 | 4 | GO:0005741 | |
| Domain | ARM-type_fold | 2.72e-05 | 339 | 49 | 7 | IPR016024 | |
| Domain | DUF1693 | 4.03e-05 | 4 | 49 | 2 | IPR012937 | |
| Domain | DUF1693 | 4.03e-05 | 4 | 49 | 2 | SM01153 | |
| Domain | NTP_transf_7 | 4.03e-05 | 4 | 49 | 2 | PF07984 | |
| Domain | P-loop_NTPase | MYH3 DNAH3 MYH8 ABCA1 RABL2B RABL2A SEPTIN4 LRRK2 DDX56 FANCM | 5.79e-05 | 848 | 49 | 10 | IPR027417 |
| Domain | ARM-like | 7.17e-05 | 270 | 49 | 6 | IPR011989 | |
| Domain | FAT | 1.00e-04 | 6 | 49 | 2 | PS51189 | |
| Domain | FATC | 1.00e-04 | 6 | 49 | 2 | PS51190 | |
| Domain | FATC_dom | 1.00e-04 | 6 | 49 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.00e-04 | 6 | 49 | 2 | IPR014009 | |
| Domain | FATC | 1.00e-04 | 6 | 49 | 2 | SM01343 | |
| Domain | PTPc | 1.14e-04 | 36 | 49 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.45e-04 | 39 | 49 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.69e-04 | 41 | 49 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.69e-04 | 41 | 49 | 3 | PF00102 | |
| Domain | PTPc_motif | 4.98e-04 | 59 | 49 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 4.98e-04 | 59 | 49 | 3 | IPR003595 | |
| Domain | - | 6.59e-04 | 746 | 49 | 8 | 3.40.50.300 | |
| Domain | Myosin_N | 6.93e-04 | 15 | 49 | 2 | PF02736 | |
| Domain | Myosin_N | 6.93e-04 | 15 | 49 | 2 | IPR004009 | |
| Domain | - | 7.90e-04 | 16 | 49 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 7.90e-04 | 16 | 49 | 2 | SM00146 | |
| Domain | Tyr_Pase_AS | 9.28e-04 | 73 | 49 | 3 | IPR016130 | |
| Domain | PI3/4_kinase_cat_dom | 1.00e-03 | 18 | 49 | 2 | IPR000403 | |
| Domain | Myosin_tail_1 | 1.00e-03 | 18 | 49 | 2 | PF01576 | |
| Domain | Myosin_tail | 1.00e-03 | 18 | 49 | 2 | IPR002928 | |
| Domain | PI3_PI4_kinase | 1.00e-03 | 18 | 49 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.00e-03 | 18 | 49 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.00e-03 | 18 | 49 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.00e-03 | 18 | 49 | 2 | PS00916 | |
| Domain | Myosin-like_IQ_dom | 1.12e-03 | 19 | 49 | 2 | IPR027401 | |
| Domain | - | 1.12e-03 | 19 | 49 | 2 | 4.10.270.10 | |
| Domain | TYR_PHOSPHATASE_1 | 1.49e-03 | 86 | 49 | 3 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 1.54e-03 | 87 | 49 | 3 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 1.54e-03 | 87 | 49 | 3 | IPR000387 | |
| Domain | - | 1.81e-03 | 92 | 49 | 3 | 3.90.190.10 | |
| Domain | Prot-tyrosine_phosphatase-like | 2.23e-03 | 99 | 49 | 3 | IPR029021 | |
| Domain | - | 2.71e-03 | 222 | 49 | 4 | 1.25.10.10 | |
| Domain | Myosin_head_motor_dom | 4.46e-03 | 38 | 49 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.46e-03 | 38 | 49 | 2 | PS51456 | |
| Domain | Myosin_head | 4.46e-03 | 38 | 49 | 2 | PF00063 | |
| Domain | MYSc | 4.46e-03 | 38 | 49 | 2 | SM00242 | |
| Pubmed | Loss of miR-17~92 results in dysregulation of Cftr in nephron progenitors. | 1.99e-06 | 17 | 51 | 3 | 30838872 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27732084 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 20138207 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10444334 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33075816 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 2.11e-06 | 2 | 51 | 2 | 30578315 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 20650929 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24220028 | ||
| Pubmed | Identification of three developmentally controlled isoforms of human myosin heavy chains. | 6.32e-06 | 3 | 51 | 2 | 1691980 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 18552351 | ||
| Pubmed | 3' RNA Uridylation in Epitranscriptomics, Gene Regulation, and Disease. | 6.32e-06 | 3 | 51 | 2 | 30057901 | |
| Pubmed | 9.48e-06 | 28 | 51 | 3 | 19114550 | ||
| Pubmed | 1.17e-05 | 30 | 51 | 3 | 18206972 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20357587 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 1985022 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 33862460 | ||
| Pubmed | Commensal bacteria direct selective cargo sorting to promote symbiosis. | 1.26e-05 | 4 | 51 | 2 | 26237551 | |
| Pubmed | The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. | 1.26e-05 | 4 | 51 | 2 | 28931820 | |
| Pubmed | ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis. | 1.26e-05 | 4 | 51 | 2 | 20431058 | |
| Pubmed | Structural and Functional Analyses of the FAM46C/Plk4 Complex. | 1.26e-05 | 4 | 51 | 2 | 32433990 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 11567631 | ||
| Pubmed | 1.57e-05 | 33 | 51 | 3 | 11564863 | ||
| Pubmed | Placentation defects are highly prevalent in embryonic lethal mouse mutants. | 1.63e-05 | 103 | 51 | 4 | 29539633 | |
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 2.10e-05 | 5 | 51 | 2 | 33241915 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.10e-05 | 5 | 51 | 2 | 3829126 | |
| Pubmed | Calpain-6 deficiency promotes skeletal muscle development and regeneration. | 2.10e-05 | 5 | 51 | 2 | 23935533 | |
| Pubmed | 2.62e-05 | 39 | 51 | 3 | 38690566 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.15e-05 | 6 | 51 | 2 | 10077619 | |
| Pubmed | Myogenin is required for late but not early aspects of myogenesis during mouse development. | 3.15e-05 | 6 | 51 | 2 | 7532173 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.15e-05 | 6 | 51 | 2 | 10588881 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 35210422 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 29288203 | ||
| Pubmed | Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity. | 4.41e-05 | 7 | 51 | 2 | 28479366 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 16720839 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 33542213 | ||
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 4.41e-05 | 7 | 51 | 2 | 15978577 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 16819597 | ||
| Pubmed | IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. | 4.41e-05 | 7 | 51 | 2 | 20383124 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 30590048 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.41e-05 | 440 | 51 | 6 | 34244565 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 21802298 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 3864153 | ||
| Pubmed | RORα-expressing T regulatory cells restrain allergic skin inflammation. | 5.87e-05 | 8 | 51 | 2 | 29500225 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 31776466 | ||
| Pubmed | Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. | 5.87e-05 | 8 | 51 | 2 | 1618148 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 27899448 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 27471270 | ||
| Pubmed | Intercrypt sentinel macrophages tune antibacterial NF-κB responses in gut epithelial cells via TNF. | 7.54e-05 | 9 | 51 | 2 | 34529751 | |
| Pubmed | FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. | 7.54e-05 | 9 | 51 | 2 | 17396147 | |
| Pubmed | Muscle-specific gene expression during myogenesis in the mouse. | 7.54e-05 | 9 | 51 | 2 | 7787235 | |
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 9.42e-05 | 10 | 51 | 2 | 2211821 | |
| Pubmed | NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. | 9.42e-05 | 10 | 51 | 2 | 33058421 | |
| Pubmed | The mahogany protein is a receptor involved in suppression of obesity. | 9.42e-05 | 10 | 51 | 2 | 10086355 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 24910428 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 9.42e-05 | 10 | 51 | 2 | 18160036 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 20519121 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 9.42e-05 | 10 | 51 | 2 | 8950513 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.15e-04 | 11 | 51 | 2 | 20427287 | |
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 34133717 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 24349473 | ||
| Pubmed | Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. | 1.15e-04 | 11 | 51 | 2 | 24051374 | |
| Pubmed | The FgfrL1 receptor is required for development of slow muscle fibers. | 1.15e-04 | 11 | 51 | 2 | 25172430 | |
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 16116422 | ||
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 1.38e-04 | 12 | 51 | 2 | 28625565 | |
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 1.38e-04 | 12 | 51 | 2 | 28600496 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.63e-04 | 13 | 51 | 2 | 8404542 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 8948582 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 27184118 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 20347429 | ||
| Pubmed | 1.94e-04 | 76 | 51 | 3 | 27542412 | ||
| Pubmed | 1.94e-04 | 76 | 51 | 3 | 19336475 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 19536649 | ||
| Pubmed | Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. | 2.19e-04 | 15 | 51 | 2 | 17289582 | |
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 18418385 | ||
| Pubmed | 2.49e-04 | 208 | 51 | 4 | 11790298 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 22090424 | ||
| Pubmed | Identification of cAMP analogue inducible genes in RAW264 macrophages. | 2.50e-04 | 16 | 51 | 2 | 11004510 | |
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 20301753 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 27760317 | ||
| Pubmed | 2.50e-04 | 16 | 51 | 2 | 20347428 | ||
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 16124007 | ||
| Pubmed | 3.18e-04 | 18 | 51 | 2 | 22343915 | ||
| Pubmed | Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1. | 3.18e-04 | 18 | 51 | 2 | 26688546 | |
| Pubmed | 3.23e-04 | 407 | 51 | 5 | 15772651 | ||
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 3.29e-04 | 91 | 51 | 3 | 30472188 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 3.34e-04 | 410 | 51 | 5 | 26949251 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 3.35e-04 | 639 | 51 | 6 | 23443559 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 3.73e-04 | 420 | 51 | 5 | 28065597 | |
| Pubmed | 3.94e-04 | 425 | 51 | 5 | 21081503 | ||
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 34127677 | ||
| Pubmed | Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. | 3.94e-04 | 20 | 51 | 2 | 7588068 | |
| Pubmed | 3.94e-04 | 20 | 51 | 2 | 22705371 | ||
| Pubmed | Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. | 4.35e-04 | 21 | 51 | 2 | 23747598 | |
| Pubmed | 4.35e-04 | 21 | 51 | 2 | 27894818 | ||
| Pubmed | 4.78e-04 | 22 | 51 | 2 | 16751104 | ||
| Pubmed | 4.78e-04 | 22 | 51 | 2 | 37468485 | ||
| Pubmed | 4.78e-04 | 22 | 51 | 2 | 24301466 | ||
| Pubmed | 5.00e-04 | 250 | 51 | 4 | 18660489 | ||
| Cytoband | Xp22.11 | 2.51e-04 | 21 | 51 | 2 | Xp22.11 | |
| Cytoband | 15q22.2 | 4.82e-04 | 29 | 51 | 2 | 15q22.2 | |
| Cytoband | 16p12.3 | 6.63e-04 | 34 | 51 | 2 | 16p12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 2.74e-03 | 250 | 51 | 3 | chrXp22 | |
| GeneFamily | RAB like GTPases | 3.22e-05 | 5 | 33 | 2 | 394 | |
| GeneFamily | Myosin heavy chains | 3.34e-04 | 15 | 33 | 2 | 1098 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 6.01e-04 | 20 | 33 | 2 | 548 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.64e-04 | 21 | 33 | 2 | 813 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-06 | 190 | 50 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.76e-06 | 197 | 50 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-06 | 109 | 50 | 4 | 0d4128af237afcc0adb4dfdd206fa3ddbe5b0e86 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-05 | 141 | 50 | 4 | dcc56aef1b31bfe0de84cb0b5c77d242681cf19c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 149 | 50 | 4 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-05 | 176 | 50 | 4 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.05e-05 | 181 | 50 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.05e-05 | 181 | 50 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 64 | 50 | 3 | 28acc0d394b8cd2fd93ae5e0801f0ff1dd4b16ac | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Npy_(Cortical_subplate_interneuron)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.13e-05 | 64 | 50 | 3 | 61414e0fa2242f156f0f45f8733b831b7f965dd8 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 5.16e-05 | 182 | 50 | 4 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.73e-05 | 187 | 50 | 4 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.85e-05 | 188 | 50 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 6.48e-05 | 193 | 50 | 4 | 7fcd6139ac3e1384a1017b6b8152e3431e056f6a | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.48e-05 | 193 | 50 | 4 | 81fdb825245cd346bf7277086b95d72a47bded73 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 194 | 50 | 4 | e72be6dc2711c1d4f16943c8615cf9dc2e961ff3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 194 | 50 | 4 | ac03be73fdc32dacd4a450c0fb28617e043b8444 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 194 | 50 | 4 | 7ab4418a8a12c488d74af3676bdac672628da80c | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.61e-05 | 194 | 50 | 4 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 194 | 50 | 4 | 760761ce7d22edf9a8cec71e8ab0caa273fce3f7 | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 6.74e-05 | 195 | 50 | 4 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | Healthy-CD8+_Tem|World / disease group, cell group and cell class | 6.74e-05 | 195 | 50 | 4 | 3d6f46b31c0254e9577a560364694b42964df198 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.74e-05 | 195 | 50 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.74e-05 | 195 | 50 | 4 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | tumor_Lung-T/NK_cells|tumor_Lung / Location, Cell class and cell subclass | 6.88e-05 | 196 | 50 | 4 | 13396bb5f0dd0dce7219d3f7a1fc1fcb6b1ee134 | |
| ToppCell | Healthy/Control-gd_T|Healthy/Control / Disease group and Cell class | 6.88e-05 | 196 | 50 | 4 | a6f9e55cd1cd7facadb3f508bded68023c997f3f | |
| ToppCell | Healthy-CD4+_CTL|Healthy / disease group, cell group and cell class | 6.88e-05 | 196 | 50 | 4 | 9da0ea4ad84d6e20e4349d3d1a8cc4d61d08c84f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.88e-05 | 196 | 50 | 4 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.88e-05 | 196 | 50 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 6.88e-05 | 196 | 50 | 4 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.88e-05 | 196 | 50 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 6.88e-05 | 196 | 50 | 4 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.01e-05 | 197 | 50 | 4 | 902e2ce011a938c1de39ff53ebbb2ec5557e48bc | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.01e-05 | 197 | 50 | 4 | 5abe983f9750085ec7b57bcb8c36bdfe78a6ee4c | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.01e-05 | 197 | 50 | 4 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 368C-Lymphocytic|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-05 | 197 | 50 | 4 | 04d069a03ed659bd93395972979a37402f500b9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.01e-05 | 197 | 50 | 4 | 836fcb20d3a1f9cf14f6fd505fbb6bad4650fd28 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.01e-05 | 197 | 50 | 4 | 8752c0f37979aa7bf2e8aee6990fb6307a6666b7 | |
| ToppCell | normal_Lung-T/NK_cells-CD8_low_T|normal_Lung / Location, Cell class and cell subclass | 7.01e-05 | 197 | 50 | 4 | 559b22ff973a1551e614a972085343e7d8e8a668 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.01e-05 | 197 | 50 | 4 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Healthy-CD8+_Tem|Healthy / disease group, cell group and cell class | 7.01e-05 | 197 | 50 | 4 | 8d60fdd5ce80c3496637fd3257d25258df6d7f75 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.15e-05 | 198 | 50 | 4 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | Healthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2) | 7.15e-05 | 198 | 50 | 4 | 25158815287efbdd8f463baa755cbb874f3905f3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_Tem|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 7.15e-05 | 198 | 50 | 4 | a7519bbbb67d319635ddbe05a2a154c46b77ce87 | |
| ToppCell | (220)_CD8+_Cytotoxic_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.15e-05 | 198 | 50 | 4 | 2af389b8ea5767ba56fe64d719afe5be3f9a43ec | |
| ToppCell | normal_Lung-T/NK_cells|normal_Lung / Location, Cell class and cell subclass | 7.15e-05 | 198 | 50 | 4 | 88efe668d1986ba1695eeb1f3768767d2927dd64 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.15e-05 | 198 | 50 | 4 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.29e-05 | 199 | 50 | 4 | 1c12b15004fa6ca9ae72a6d6f8f9a5fdeb755bd1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.29e-05 | 199 | 50 | 4 | c8c89779dda4dcfb26bf86492c2e5a4f158eb8d2 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.29e-05 | 199 | 50 | 4 | fe6f2e85df56057907c711e68629c57a3b3d3e05 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 7.29e-05 | 199 | 50 | 4 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-gd_T|ICU-NoSEP / Disease, condition lineage and cell class | 7.44e-05 | 200 | 50 | 4 | 2c2cea7691c340912f6ad77667a580a071eaeb8b | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 7.44e-05 | 200 | 50 | 4 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-04 | 130 | 50 | 3 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.98e-04 | 138 | 50 | 3 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | (00)_Basal|World / shred by cell type and Timepoint | 6.22e-04 | 149 | 50 | 3 | 49e39206f37cee124ca4763c79425b805e50624b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-04 | 150 | 50 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.35e-04 | 150 | 50 | 3 | fdbfc8f743cf848978cf0488493f6df60be53982 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.35e-04 | 150 | 50 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_CTL|Int-URO / Disease, Lineage and Cell Type | 6.72e-04 | 153 | 50 | 3 | fdc7dfa8f4db90bfdc7180bf178cf6d2dd064d97 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.51e-04 | 159 | 50 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | Control-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 7.51e-04 | 159 | 50 | 3 | 6f50c381cd8a26a5a90bf0ce909713cea96910d7 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.93e-04 | 162 | 50 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.93e-04 | 162 | 50 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.07e-04 | 163 | 50 | 3 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.51e-04 | 166 | 50 | 3 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | COVID-19-APC-like-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 8.66e-04 | 167 | 50 | 3 | 854a5dbd43f2b25825a71d37fd7779507783a99a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-04 | 168 | 50 | 3 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_CTL|ICU-NoSEP / Disease, Lineage and Cell Type | 8.96e-04 | 169 | 50 | 3 | cbda36f32bd78322dcfe303a44413415d08e5ea3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.96e-04 | 169 | 50 | 3 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 9.12e-04 | 170 | 50 | 3 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.12e-04 | 170 | 50 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.27e-04 | 171 | 50 | 3 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | Control-MAIT|Control / Disease group and Cell class | 9.43e-04 | 172 | 50 | 3 | 552bc62e8e8bb0ac1cd0452f4410a3af087787eb | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-04 | 172 | 50 | 3 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.59e-04 | 173 | 50 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 9.59e-04 | 173 | 50 | 3 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 9.59e-04 | 173 | 50 | 3 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK_CD56bright|Int-URO / Disease, Lineage and Cell Type | 9.75e-04 | 174 | 50 | 3 | 93c7acd5941a5f235ec4c57461f78ee2871e7336 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-04 | 175 | 50 | 3 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.91e-04 | 175 | 50 | 3 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.91e-04 | 175 | 50 | 3 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 1.01e-03 | 176 | 50 | 3 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.01e-03 | 176 | 50 | 3 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.02e-03 | 177 | 50 | 3 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-03 | 177 | 50 | 3 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 3'_v3|World / Manually curated celltypes from each tissue | 1.04e-03 | 178 | 50 | 3 | 42502f14d9c756df8104900ac6484477b885d3d9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-03 | 178 | 50 | 3 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | IIF-Lymphocyte-T_NK-gdT|IIF / Disease, Lineage and Cell Type | 1.04e-03 | 178 | 50 | 3 | 3344d1328fd9c570c3a4b2629edec627a442d0e0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-03 | 178 | 50 | 3 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-03 | 180 | 50 | 3 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | control-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.07e-03 | 180 | 50 | 3 | 592fb72cc344efff1bd3376d9f28c79745c61469 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|normal_Lung / Location, Cell class and cell subclass | 1.09e-03 | 181 | 50 | 3 | f74941e49950027360d71ea3b205fc20c6929766 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 181 | 50 | 3 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 181 | 50 | 3 | 1db1eb7d330a7e5090994007ae287e11f0a74450 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 181 | 50 | 3 | 06174ce9240c9261c0f51a1b0d875335d60722e5 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 181 | 50 | 3 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-03 | 182 | 50 | 3 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-03 | 182 | 50 | 3 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| Drug | salicyl-AMP | 4.35e-06 | 2 | 48 | 2 | CID000636428 | |
| Disease | Distal arthrogryposis | 3.37e-07 | 9 | 48 | 3 | cv:C0265213 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 3.87e-05 | 6 | 48 | 2 | C1834523 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.13e-04 | 153 | 48 | 4 | EFO_0004611, EFO_0020944 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.16e-04 | 10 | 48 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | prediabetes syndrome (biomarker_via_orthology) | 1.69e-04 | 12 | 48 | 2 | DOID:11716 (biomarker_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.00e-04 | 13 | 48 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 2.33e-04 | 14 | 48 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.68e-04 | 15 | 48 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Bone marrow hypocellularity | 3.90e-04 | 18 | 48 | 2 | C1855710 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 5.19e-04 | 96 | 48 | 3 | EFO_0004529, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 5.68e-04 | 99 | 48 | 3 | EFO_0004639, EFO_0008595 | |
| Disease | Ovarian Serous Adenocarcinoma | 6.41e-04 | 23 | 48 | 2 | C1335177 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 6.56e-04 | 104 | 48 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | Fanconi Anemia | 7.59e-04 | 25 | 48 | 2 | C0015625 | |
| Disease | Pancytopenia | 8.21e-04 | 26 | 48 | 2 | C0030312 | |
| Disease | Acute monocytic leukemia | 8.21e-04 | 26 | 48 | 2 | C0023465 | |
| Disease | free cholesterol measurement | 8.34e-04 | 113 | 48 | 3 | EFO_0008591 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 8.56e-04 | 114 | 48 | 3 | EFO_0004574, EFO_0004611 | |
| Disease | Colorectal Carcinoma | 9.31e-04 | 702 | 48 | 6 | C0009402 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 9.93e-04 | 120 | 48 | 3 | EFO_0004611, EFO_0004639 | |
| Disease | Miller Dieker syndrome | 1.02e-03 | 29 | 48 | 2 | C0265219 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.09e-03 | 30 | 48 | 2 | C1868672 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 1.14e-03 | 126 | 48 | 3 | EFO_0004611, EFO_0010351 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.17e-03 | 31 | 48 | 2 | C1335167 | |
| Disease | Abnormality of radial ray | 1.32e-03 | 33 | 48 | 2 | C4228778 | |
| Disease | allergic rhinitis | 1.34e-03 | 133 | 48 | 3 | EFO_0005854 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.45e-03 | 137 | 48 | 3 | EFO_0007795, EFO_0010724 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.45e-03 | 137 | 48 | 3 | EFO_0004611, EFO_0008591 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYPEVVRMVSCNIFR | 111 | Q16537 | |
| RYQSMRRDVIGCTQE | 96 | Q9GZU0 | |
| TNQAIRTISRFMECV | 491 | O95477 | |
| VISFTFQMAVQRCVV | 171 | Q9NVT9 | |
| VVQANRRCQDMEYTI | 741 | Q8IY63 | |
| ENMCSRVQYRQISRA | 441 | P24386 | |
| VDMNVVRICFQASYR | 261 | Q01201 | |
| ACIMVFDIQRKVTYR | 96 | Q9UBK7 | |
| ACIMVFDVQRKVTYR | 96 | Q9UNT1 | |
| VLMEERNVFCGTYNV | 391 | O95170 | |
| NGCDYIVSNRMVVER | 1851 | Q8IYD8 | |
| MIQQLATYCARDVRV | 101 | Q9NY93 | |
| TQAVCRGFLMRVEYQ | 791 | P13535 | |
| VCRNFMRRYQSRVTQ | 106 | P22749 | |
| QERTRCMIEIGVAFY | 1261 | Q9ULK4 | |
| CRRMVVVVSDDYLQS | 216 | Q99836 | |
| RVIYNFCNSVRVMMT | 2446 | Q5S007 | |
| NQVMDFRTQLIRLCY | 106 | P21266 | |
| RRYTVQFTTMVQVNE | 1656 | Q7Z6Z7 | |
| VCSQQYRFSIVMNEL | 171 | Q27J81 | |
| CSRRVNMIQTEEQYI | 1121 | Q92729 | |
| QRMMLVQTLCQYTFV | 1146 | Q16825 | |
| ILIIYSRNQTVMFQC | 716 | Q8NB91 | |
| NIRVEVVSMCKYFQE | 2616 | Q8TD57 | |
| YERCSRRNMYVNIAV | 76 | P0C843 | |
| QQDMVCYTAQTLVRI | 306 | Q12905 | |
| TCFVSQQRVREVYLM | 1646 | Q9Y238 | |
| VICFMQFVHIAYQVR | 86 | Q9HBV1 | |
| YGFVSRIRAQRCQMV | 471 | P18433 | |
| RAQEIGYTVCLIQMF | 106 | Q8NGH6 | |
| TFSSQVCRVAYEIMQ | 466 | Q9BYC5 | |
| CVIVEVRDYRQSSNM | 141 | Q3ZLR7 | |
| NYRAQCIQSMTRLVV | 406 | O43236 | |
| YCQVIRVIAHTQMRL | 156 | P39023 | |
| DVLYRVMRCVTAANQ | 431 | Q96Q15 | |
| VNESTVCLMSYERRQ | 306 | Q8NEK8 | |
| SIFCIQYNIRSFMNV | 811 | P11055 | |
| VFVCRVSAVLFYVNM | 91 | Q15391 | |
| RYNIIMNRHTCNFVV | 131 | Q8NGU2 | |
| YLMILRRVVNESTVC | 306 | Q5VWP2 | |
| CVIVEVRDYRQSSNM | 141 | P0C7V6 | |
| VVMYCRVYVVARSTT | 271 | P25100 | |
| IMRNAIVNCAEVVTY | 186 | P55916 | |
| VSCSQISIVMVYFQL | 546 | Q92544 | |
| IHSMRCRNRLYVIQT | 761 | Q0IIM8 | |
| IRMCRAFDSQNNTVY | 366 | P35398 | |
| QVSQAIRYMEFCVNV | 641 | Q9P253 | |
| NTLVARSEMVCYFVI | 1916 | Q9H5I5 | |
| VNCSMSYQRSREQIL | 261 | Q709C8 | |
| CQMSNITVTYRDGRV | 41 | P62318 | |
| RNDVVYVCRVVSAMI | 216 | Q96PF1 | |
| GQTYIRVANCQTVRM | 611 | Q9Y4A5 |